Patrick G. Enright

Co-Founder at Longitude Capital Management Co. LLC

Patrick G. Enright

Patrick G. Enright

Co-Founder at Longitude Capital Management Co. LLC

Overview
Career Highlights

Urigen Pharmaceuticals, Inc.
Valentis, Inc.
Longitude Capital Management Co. LLC

RelSci Relationships

1110

Number of Boards

26

Birthday

1962

Age

58

Contact Data
Trying to get in touch with Patrick G. Enright? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Patrick G. Enright likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Co-Founder at Jazz Pharmaceuticals Plc

Relationship likelihood: Strong

Managing Director at Sutter Hill Ventures LLC

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Orbus Therapeutics, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer, Director at Aptinyx, Inc.

Relationship likelihood: Strong

Venture Partner at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Associate Professor of Pediatrics & Neonatology at Stanford University - School of Medicine

Relationship likelihood: Strong

Venture Partner at SHVMS, LLC

Relationship likelihood: Strong

Paths to Patrick G. Enright
Potential Connections via
Relationship Science
You
Patrick G. Enright
Co-Founder at Longitude Capital Management Co. LLC
Education
M.B.A.

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

BS Biology

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
Co-Founder
2006 - Current

Longitude Capital invests in growth capital investments in biotechnology and medical technology. They consider companies across all therapeutic indications and stages of development.

Professional
Prior - 2001

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Chief Financial Officer & Senior Vice President
Prior - 2007

Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.

Boards & Committees
Director
2018 - Current

Curasen Therapeutics, Inc. engages in the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda on April 18, 2016 and is headquartered in Los Altos Hills, CA.

Independent Director
2016 - Current

Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Member, Board of Directors
2015 - Current

Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.

Member, Board of Directors
2019 - Current

As the voice of the U.S. venture capital community, the National Venture Capital Association (NVCA) empowers its members and the entrepreneurs they fund by advocating for policies that encourage innovation and reward long-term investment. As the venture community’s preeminent trade association, NVCA serves as the definitive resource for venture capital data and unites its 400 plus members through a full range of professional services.

Political Donations
$500
2003

Former Senator from Connecticut

$500
2003

Former Senator from Connecticut

Transactions
Details Hidden

Jazz Pharmaceuticals Plc issued USD Ordinary Shares

Details Hidden

Longitude Capital Associates II LP raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patrick G. Enright. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patrick G. Enright's profile does not indicate a business or promotional relationship of any kind between RelSci and Patrick G. Enright.